Compare Innodata Inc (INOD) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs Revvity Inc — how do they compare? Innodata Inc trades at $61.54 (market cap $2.05B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 6.3× Innodata Inc's market cap, and Revvity Inc pays a 0.24% dividend while Innodata Inc pays none. Which is the better fit depends on your goals.
| INOD | RVTY | |
|---|---|---|
Market Cap | $2.05B | $12.91B |
Sector | Technology | Technology |
52-Week High | $121.50 | $117.75 |
52-Week Low | $34.45 | $82.26 |
Enterprise Value | $1.80B | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INOD trades at $61.47, down 1.21% today, but maintains strong technical support at $60-$62 levels with bullish oscillators and mixed moving averages. The company demonstrates robust fundamental performance with 58% year-over-year revenue growth in Q2 2026, beating earnings estimates for three consecutive quarters, and expanding profit margins to 14.66%. Recent AI-driven business developments and strong analyst coverage support the positive momentum.
INOD presents a compelling growth opportunity with accelerating AI services demand and consistent earnings outperformance, though premium valuation metrics (P/E 48.6, P/S 6.8) warrant caution. Key risks include customer concentration and competitive pressures in the rapidly evolving AI sector. Analyst consensus remains bullish with a $130 price target representing 111% upside potential from current levels.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
